1. 185 Secukinumab demonstrates consistent safety over long-term exposure in patients with psoriatic arthritis and moderate-to-severe plaque psoriasis: updated pooled safety analyses. (25th April 2018) Authors: McInnes, Iain; Mease, Philip; Reich, Kristian; Nash, Peter; Andersson, Mats; Abrams, Ken; Pricop, Luminita; Fox, Todd Journal: Rheumatology Issue: Volume 57(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease. Issue 9 (6th June 2014) Authors: Sibley, Cailin H; Chioato, Andrea; Felix, Sandra; Colin, Laurence; Chakraborty, Abhijit; Plass, Nikki; Rodriguez-Smith, Jackeline; Brewer, Carmen; King, Kelly; Zalewski, Christopher; Kim, H Jeffrey; Bishop, Rachel; Abrams, Ken; Stone, Deborah; Chapelle, Dawn; Kost, Bahar; Snyder, Christopher; But... Journal: Annals of the rheumatic diseases Issue: Volume 74:Issue 9(2015) Page Start: 1714 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome. Issue 1 (29th July 2016) Authors: Torene, Rebecca; Nirmala, Nanguneri; Obici, Laura; Cattalini, Marco; Tormey, Vincent; Caorsi, Roberta; Starck-Schwertz, Sandrine; Letzkus, Martin; Hartmann, Nicole; Abrams, Ken; Lachmann, Helen; Gattorno, Marco Journal: Annals of the rheumatic diseases Issue: Volume 76:Issue 1(2017) Page Start: 303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study. Issue 1 (7th June 2016) Authors: Gattorno, Marco; Obici, Laura; Cattalini, Marco; Tormey, Vincent; Abrams, Ken; Davis, Nicole; Speziale, Antonio; Bhansali, Suraj G; Martini, Alberto; Lachmann, Helen J Journal: Annals of the rheumatic diseases Issue: Volume 76:Issue 1(2017) Page Start: 173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy. Issue 1 (December 2017) Authors: Brachat, Arndt; Grom, Alexei; Wulffraat, Nico; Brunner, Hermine; Quartier, Pierre; Brik, Riva; McCann, Liza; Ozdogan, Huri; Rutkowska-Sak, Lidia; Schneider, Rayfel; Gerloni, Valeria; Harel, Liora; Terreri, Maria; Houghton, Kristin; Joos, Rik; Kingsbury, Daniel; Lopez-Benitez, Jorge; Bek, Stephan;... Journal: Arthritis research & therapy Issue: Volume 19:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP0055 EFFICACY OF CANAKINUMAB, ON A REDUCED DOSE OR A PROLONGED DOSE INTERVAL WITHOUT CONCOMITANT CORTICOSTEROIDS AND METHOTREXATE, IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS. (June 2019) Authors: Quartier, Pierre; Alexeeva, Ekaterina; Wouters, Carine; Calvo, Inmaculada; Kallinich, Tilmann; Wulffraat, Nico; Wei, Xiaoling; Slade, Alan; Abrams, Ken; Martini, Alberto Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OP0114 MACHINE LEARNING TOOLS IDENTIFY PATIENT CLUSTERS AND SWOLLEN AND TENDER JOINT CORRELATION PATTERNS IN A LARGE DATABASE FROM THE SECUKINUMAB PSORIATIC ARTHRITIS CLINICAL DEVELOPMENT PROGRAM. (June 2019) Authors: Kormaksson, Matthias; Pournara, Effie; Ligozio, Gregory; Pricop, Luminita; Abrams, Ken; Kirkham, Bruce; Reich, Kristian; McInnes, Iain Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacokinetics and Pharmacodynamics of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis. (8th June 2016) Authors: Sun, Haiying; Van, Linh M.; Floch, David; Jiang, Xuemin; Klein, Ulf R.; Abrams, Ken; Sunkara, Gangadhar Journal: Journal of clinical pharmacology Issue: Volume 56:Number 12(2016) Page Start: 1516 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab. Issue 1 (January 2016) Authors: Grom, Alexei A.; Ilowite, Norman T.; Pascual, Virginia; Brunner, Hermine I.; Martini, Alberto; Lovell, Daniel; Ruperto, Nicolino; Leon, Karolynn; Lheritier, Karine; Abrams, Ken Other Names: Cuttica Ruben investigator.; Emminger Wolfgang investigator.; Goffin Laurence investigator.; Joos Rik investigator.; Lauwerys Bernard investigator.; Wouters Carine investigator.; Hilário Maria Odete Esteves investigator.; de Oliveira Sheila Knupp Feitosa investigator.; Len Claudio investigator.; ... Journal: Arthritis & rheumatology Issue: Volume 68:Issue 1(2016) Page Start: 218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab. Issue 1 (January 2016) Authors: Grom, Alexei A.; Ilowite, Norman T.; Pascual, Virginia; Brunner, Hermine I.; Martini, Alberto; Lovell, Daniel; Ruperto, Nicolino; Leon, Karolynn; Lheritier, Karine; Abrams, Ken Journal: Arthritis & rheumatology Issue: Volume 68:Issue 1(2016) Page Start: 218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗